AIP
IONS icon

Ameritas Investment Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Ameritas Investment Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,373
Closed -$660K – 1188
2015
Q1 		$660K Hold
10,373
– – 0.04% 473
2014
Q4 		$640K Sell
10,373
-163
-2% -$8.04K 0.04% 459
2014
Q3 		$409K Hold
10,536
– – 0.03% 660
2014
Q2 		$363K Buy
10,536
+800
+8% +$25.2K 0.03% 753
2014
Q1 		$421K Hold
9,736
– – 0.03% 647
2013
Q4 		$388K Buy
9,736
+51
+0.5% +$1.82K 0.03% 696
2013
Q3 		$364K Buy
+9,685
New +$289K 0.03% 658

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Ameritas Investment Partners's IONS Position: Q2 2015 in Review

Ameritas Investment Partners sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 10,373 shares — an estimated $660K sold.

Ameritas Investment Partners first reported a position in IONS in Q3 2013 and held it in 7 quarters. The position peaked at $660K in Q1 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

  • Ameritas Investment Partners reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Ameritas Investment Partners sold 10,373 Ionis Pharmaceuticals shares in Q2 2015, an estimated $660K.
  • Ameritas Investment Partners first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Ameritas Investment Partners's Ionis Pharmaceuticals position peaked at $660K in Q1 2015.
  • 353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Ameritas Investment Partners's 13F filing for Q2 2015, filed 7 Aug 2015.